1. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (1st March 2022) Authors: Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P374: BLINATUMOMAB AS CONSOLIDATION FOR ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. A REAL-WORLD STUDY. (23rd June 2022) Authors: Urbino, I.; Lengline, E.; Cerrano, M.; Rabian, F.; Kim, R.; Sebert, M.; Itzykson, R.; Audisio, E.; Ades, L.; Dombret, H.; Raffoux, E.; Ferrero, D.; Clappier, E.; Boissel, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗